34
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Measurement of quality of life for people with diabetic retinopathy impairment

, , &
Pages 587-593 | Published online: 09 Jan 2014

References

  • Lamoureux EL, Hassell JB, Keeffe JE. The impact of diabetic retinopathy on participation in daily living. Arch. Ophthalmol.122(1), 84–88 (2004).
  • Coyne K, Margolisa M, Kennedy-Martinb T et al. The impact of diabetic retinopathy: perspectives from patient focus groups. Family Practice21(4), 447–453 (2004).
  • Woodcock A, Bradley C, Plowright R, Ffytche T, Kennedy-Martin T, Hirsch A. The influence of diabetic retinopathy on quality of life: interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. Patient Educ. Couns.53(3), 365–383 (2004).
  • Sharma S, Oliver-Fernandez A, Liu W, Buchholz P, Walt J. The impact of diabetic retinopathy on health-related quality of life. Curr. Opin. Ophthalmol.16(3), 155–159 (2005).
  • Davidov E, Breitscheidel L, Clouth J, Reips M, Happich M. Diabetic retinopathy and health-related quality of life. Clin. Experiment. Ophthalmol.247(2), 267–272 (2009).
  • Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J. The economic burden of diabetic retinopathy in Germany in 2002. Graefes Arch. Clin. Exp. Ophthalmol.246, 151–159 (2007).
  • Access Economics Pty Limited. The Economic Impact of Partial Sight and Blindness in the UK. Royal National Institute of Blind People, London, UK (2009).
  • The WHOQoL Group. The development of the World Health Organization Quality of Life Assessment Instrument (the WHOQoL). In: Quality of Life Assessment: International Perspectives. Orley J, Kuyken W (Eds). Springer-Verlag, Heidleberg, Germany (1994).
  • WHO. The International Classification of Functioning, Disability and Health. WHO, Geneva, Switzerland (2001).
  • Gabrielian A, Hariprasad S, Jager R, Green J, Mieler W. The utility of visual function questionnaire in the assessment of the impact of diabetic retinopathy on vision-related quality of life. Eye DOI: 10.1038/eye.2009.56 (2009) (Epub ahead of print).
  • Stein J. Disparities between ophthalmologists and their patients in estimating quality of life. Curr. Opin. Ophthalmol.15(3), 238–243 (2004).
  • Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J. Epidemiol. Community Health53, 46–50 (1999).
  • Matza L, Rousculp M, Malley K, Boye K, Oglesby A. The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy. Health Qual. Life Outcomes6(95) (2008).
  • Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J. Clin. Epidemiol.56, 52–60 (2003).
  • Margolis MK, Coyne K, Kennedy-Martin T, Baker T, Schein O, Revicki DA. Vision-specific instruments for the assessment of health-related quality of life and visual functioning – a literature review. Pharmacoeconomics20(12), 791–812 (2002).
  • Massof RW, Rubin GS. Visual function assessment questionnaires. Surv. Ophthalmology45, 531–548 (2001).
  • Burmedi D, Becker S, Heyl V, Wahl H-W, Himmelsbach I. Behavioral consequences of age-related low vision. Vis. Impair. Res.4(1), 15–45 (2002).
  • de Boer MR, Pluijm SM, Lips P et al. Different aspects of visual impairment as risk factors for falls and fractures in older men and women. J. Bone Miner. Res.19(9), 1539–1547 (2004).
  • Scott IU SO, West S, Bandeen-Roche K, Enger C, Folstein MF. Functional status and quality of life measurement among ophthalmic patients. Arch. Ophthalmol.112, 329–335 (1994).
  • Frost NA, Sparrow JM, Durant JS, Donovan JL, Peters TJ, Brookes ST. Development of a questionnaire for measurement of vision-related quality of life. Ophthalmic Epidemiol.5(4), 185–210 (1998).
  • Wolffsohn JS, Cochrane AL. Design of the low vision quality of life questionnaire (LVQOL) and measuring the outcome of low-vision rehabilitation. Am. J. Ophthalmol.130, 793–802 (2000).
  • Massof RW, Fletcher DC. Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Res.41, 397–413 (2001).
  • Weih LM, Hassell JB, Keeffe J. Assessment of the impact of vision impairment. Invest. Ophthalmol. Vis. Sci.43(4), 927–935 (2002).
  • Nelson P, Aspinall P, O’Brien C. Patients’ perception of visual impairment in glaucoma: a pilot study. Br. J. Ophthalmol.83(5), 546–552 (1999).
  • Crabtree H, Hildreth A, O’Connell J et al. Measuring visual symptoms in British cataract patients: the cataract symptom scale. Br. J. Ophthalmol.83, 519–523 (1999).
  • Steinberg EP, Javitt JC, Legro MW et al. The VF-14. An index of functional impairment in patients with cataract. Arch. Ophthalmol.112(5), 630–638 (1994).
  • de Boer MR, Moll AC, de Vet HC, Terwee CB, Volker-Dieben HJ, van Rens GH. Psychometric properties of vision-related quality of life questionnaires: a systematic review. Ophthalmic Physiol. Opt.24(4), 257–273 (2004).
  • Lamoureux EL, Pesudovs K, Pallant JF et al. An evaluation of the 10-item Vision Core Measure 1 (VCM1) Scale (the core module of the Vision-Related Quality of Life scale) using Rasch analysis. Ophthalmic Epidemiol.15(4), 224–233 (2008).
  • de Boer MR, Terwee CB, de Vet HC, Moll AC, Volker-Dieben HJ, van Rens GH. Evaluation of cross-sectional and longitudinal construct validity of two vision-related quality of life questionnaires: the LVQOL and VCM1. Qual. Life Res.15(2), 233–248 (2006).
  • de Boer MR, de Vet HC, Terwee CB, Moll AC, Volker-Dieben HJ, van Rens GH. Changes to the subscales of two vision-related quality of life questionnaires are proposed. J. Clin. Epidemiol.58(12), 1260–1268 (2005).
  • Lamoureux E, Pallant J, Pesudovs K, Rees G, Hassell J, Keeffe J. The Impact of Vision Impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and Rasch analysis. Invest. Ophthalmol. Vis. Sci.48(3), 1001–1006 (2007).
  • Lamoureux EL, Pallant JF, Pesudovs K, Hassell JB, Keeffe JE. The Impact of Vision Impairment questionnaire: an evaluation of its measurement properties using Rasch analysis. Invest. Ophthalmol. Vis. Sci.47(11), 4732–4741 (2006).
  • Lamoureux EL, Pallant JF, Pesudovs K et al. Assessing participation in daily living and the effectiveness of rehabilitation in age related macular degeneration patients using the Impact of Vision Impairment scale. Ophthalmic Epidemiol.15(2), 105–113 (2008).
  • Weih LM, Hassell JB, Keeffe JE. Reliability of the Impact of Vision Impairment Questionnaire. Invest. Ophthalmol. Vis. Sci.42(4), S859–S861 (2001).
  • Lamoureux EL, Pallant JF, Pesudovs K, Rees G, Hassell JB, Keeffe JE. The effectiveness of low vision rehabilitation on participation in daily living and quality of life. Invest. Ophthalmol. Vis. Sci.48(4), 1476–1482 (2007).
  • Cochrane G, Lamoureux E, Keeffe J. Defining the content for a new quality of life questionnaire for students with low vision (the Impact of Vision Impairment on Children: IVI_C). Ophthalmic Epidemiol.15(2), 114–120 (2008).
  • O’Connor PM, Scarr BC, Lamoureux EL, Le Mesurier RT, Keeffe JE. Adaptation and validation of a quality of life questionnaire for use in the Pacific Islands. Invest. Ophthalmol. Vis. Sci.49, E-Abstract 3147 (2008).
  • Ferraz MB. Adaptation of a questionnaire to evaluate the quality of life of patients with cataracts. Arch. Brazil Ophthalmol.65, 293–298 (2002).
  • Cahill M, Banks A, Stinnett S, Toth C. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology112(1), 152–158 (2005).
  • Deramo V, Cox T, Syed A, Lee P, Fekrat S. Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Arch. Ophthalmol.121, 1297–1302 (2003).
  • Nordmann J, Viala M, Sullivan K, Arnould B, Berdeaux G. Psychometric validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics22(3), 197–206 (2004).
  • Ma S, Shea J, Galetta S et al. Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. Am. J. Ophthalmol.133, 686–692 (2002).
  • Globe DR, Varma R, Torres M, Wu J, Klein R, Azen SP. Self-reported comorbidities and visual function in a population-based study: The Los Angeles Latino Eye Study. Arch. Ophthalmol.123(6), 815–821 (2005).
  • Stelmack JA, Stelmack TR, Massof RW. Measuring low-vision rehabilitation outcomes with the NEI VFQ-25. Invest. Ophthalmol. Vis. Sci.43(9), 2859–2868 (2002).
  • O’Connor P, Keeffe J, Pesudovs K, Marella M, Lamoureux E. Comparing the psychometric performance of the impact of vision impairment (IVI) and the National Eye Institute Functioning Questionnaire-25 (NEI VFQ-25). Invest. Ophthalmol.50, E-Abstract 3203, A394 (2009).
  • Unver YB, Yavuz GA, Sinclair SH. Interactive, computer-based, self-reported, visual function questionnaire: the PalmPilot-VFQ. Eye23(7), 1572–1581 (2009).
  • Suzukamo Y, Oshika T, Yuzawa M et al. Psychometric properties of the 25-item National Eye Health Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health Qual. Life Outcomes3, 65 (2005).
  • Toprak A, Eser E, Guler C, Baser F, Mayali H. Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiol.12(4), 259–269 (2005).
  • Rossi G, Milano G, Tinelli C. The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliability. J. Glaucoma.12(3), 213–220 (2003).
  • Magacho L, Lima FE, Nery ACS, Sagawa A, Magacho B, Avila MP. Quality of life in glaucoma patients: regression analysis and correlation with possible modifiers. Ophthalmic Epidemiol.11(4), 263–270 (2004).
  • Globe D, Varma R, Azen S, Paz SH, Yu E, Preston-Martin S; Los Angeles Eye Study Group. Pyschometric performance of the NEI VFQ-25 in visually normal latinos: The Los Angeles Latino Eye Study. Invest. Ophthalmol. Vis. Sci.44(4), 1470–1478 (2003).
  • Labiris G, Katsanos A, Fanariotis M et al. Psychometric properties of the Greek version of the NEI-VFQ 25. BMC Ophthalmol.8, 4 (2008).
  • Brown M, Brown G, Sharma S, Landy J, Bakal J. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch. Ophthalmol.120, 481–484 (2002).
  • Ahmadian L, Massof R. Does functional vision behave differently in low-vision patients with diabetic retinopathy? A case-matched study. Invest. Ophthalmol.49(9), 4051–4057 (2008).
  • Hariprasad SM, Mieler WF, Grassi M, Green JL, Jager RD, Miller L. Vision-related quality of life in patients with diabetic macular oedema. Br. J. Ophthalmol.92(1), 89–92 (2008).
  • Sharma S, Oliver-Fernandez A, Bakal J, Hollands H, Brown G, Brown MM. Utilities associated with diabetic retinopathy: results from a Canadian sample. Br. J. Ophthalmol.87(3), 259–261 (2003).
  • Tung T, Chen S, Lee F, Liu J, Lin C, Chou P. A community-based study for the utility values associated with diabetic retinopathy among Type 2 diabetics in Kinmen, Taiwan. Diabetes Res. Clin. Pract.68, 265–273 (2005).
  • Okamoto F, Okamotoa Y, Fukudaa S, Hiraokaa T, Oshikaa T. Vision-related quality of life and visual function following vitrectomy for proliferative diabetic retinopathy. Am. J. Ophthalmol.145(6), 1031–1036 (2008).
  • Noe G, Ferraro J, Lamoureux E, Rait J, Keeffe JE. Associations between glaucomatous visual field loss and participation in activities of daily living. Clin. Experiment. Ophthalmol.31(6), 482–486 (2003).
  • Vu HT, Keeffe JE, McCarty CA, Taylor HR. Impact of unilateral and bilateral vision loss on quality of life. Br. J. Ophthalmol.89(3), 360–363 (2005).
  • Chia EM, Wang JJ, Rochtchina E, Smith W, Cumming RR, Mitchell P. Impact of bilateral visual impairment on health-related quality of life: The Blue Mountains Eye Study. Invest. Ophthalmol. Vis. Sci.45(1), 71–76 (2004).
  • Lamoureux EL, Hassell JB, Keeffe JE. The determinants of participation in activities of daily living in people with impaired vision. Am. J. Ophthalmol.137(2), 265–270 (2004).
  • Klein R, Moss SE, Klein BE, Gutierrez P, Mangione CM. The NEI-VFQ-25 in people with long-term Type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch. Ophthalmol.119(5), 733–740 (2001).
  • Knudtson MD, Klein BEK, Klein R, Cruickshanks KJ, Lee KE. Age-related eye disease, quality of life, and functional activity. Arch. Ophthalmol.123(6), 807–814 (2005).
  • Lamoureux E, Tai E, Thumboo J et al. Impact of diabetic retinopathy on vision-specific function. Ophthalmology (2009) (In press).
  • Mozaffarieh M, Krepler K, Heinzl H, Sacu S, Wedrich A. Visual function, quality of life and patient satisfaction after ophthalmic surgery: a comparative study Opthalmologica218(1), 26–30 (2004).
  • Tranos P, Topouzis F, Stangos N et al. Effect of laser photocoagulation treatment for diabetic macular oedema on patient’s vision-related quality of life. Curr. Eye Res.29(1), 41–49 (2004).
  • Hinds A, Sinclair A, Park J, Suttie A, Paterson H, Macdonald M. Impact of an interdisciplinary low vision service on the quality of life of low vision patients. Br. J. Ophthalmol.87(11), 1391–1396 (2003).
  • Hart P, Chakravarthy U, Stevenson M. Questionnaire-based survey on the importance of quality of life measures in ophthalmic practice. Eye12(1), 124–126 (1998).
  • Taenzer P, Bultz B, Carlson L et al. Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients. Psychooncology9(3), 203–213 (1997).
  • Detmar S, Muller M, Schornagel J, Wever L, Aaronson N. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA288(3), 3027–3034 (2002).
  • O’Connor PM, Lamoureux EL, Keeffe JE. Predicting the need for low vision rehabilitation services. Br. J. Ophthalmol.92 (2), 252–255 (2008).
  • Frank-Stromborg M, Olsen S. Instruments for clinical health-care research (3rd Edition). Jones and Bartlett Publishers International, London, UK (2004).
  • Bond T, Fox C. Applying the Rasch Model: Fundamental Measurement in the Human Sciences. Lawrence Erlbaum Associates, NJ, USA (2007).
  • Stelmack J, Massof R, Szlyk J, Wright B, Stelmack T. A comparison of outcomes in VA blind rehabilitation and VICTORS using the NEI VFQ-25. Optom. Vis. Sci.77(Suppl.), 241 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.